Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Redeia unit Red Eléctrica completes Calatorao 220 kV substation project, invests EUR 8.8 million

Redeia unit Red Eléctrica completes Calatorao 220 kV substation project, invests EUR 8.8 million

ReutersReuters2026/09/09 07:31
  • Redeia completed a new 220 kV Calatorao substation in Zaragoza province, now in service, to supply power for industrial and technology projects.
  • The project includes a 1.5 km double-circuit line linking the site to the Jalón–Los Vientos 220 kV transmission line.
  • Total investment reached EUR 8.8 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Redeia Corporación SA published the original content used to generate this news brief on September 09, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas